VWF and endothelial dysfunction: Furthermore, if endothelial dysfunction is validated in future large-scale studies, ADAMTS13 level and the ADAMTS13/VWF ratio might be used in clinical practice to monitor the progression of endothelial dysfunction, and these biomarkers might become other therapeutical targets in patients with LVNC.